ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 36 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,721,000 | +30.8% | 1,784,913 | +0.7% | 1.90% | +25.8% |
| Q3 2021 | $18,906,000 | -18.3% | 1,771,844 | -31.1% | 1.51% | -29.1% |
| Q2 2021 | $23,143,000 | -15.1% | 2,571,450 | 0.0% | 2.13% | -2.4% |
| Q1 2021 | $27,257,000 | -15.9% | 2,571,450 | 0.0% | 2.19% | -12.4% |
| Q4 2020 | $32,400,000 | +43.3% | 2,571,450 | 0.0% | 2.50% | +23.0% |
| Q3 2020 | $22,603,000 | -9.5% | 2,571,450 | 0.0% | 2.03% | -7.5% |
| Q2 2020 | $24,969,000 | +237.1% | 2,571,450 | 0.0% | 2.19% | +161.1% |
| Q1 2020 | $7,406,000 | -25.0% | 2,571,450 | 0.0% | 0.84% | -49.3% |
| Q4 2019 | $9,874,000 | -3.0% | 2,571,450 | 0.0% | 1.66% | -48.0% |
| Q3 2019 | $10,183,000 | -5.9% | 2,571,450 | 0.0% | 3.18% | +14.8% |
| Q2 2019 | $10,826,000 | -38.6% | 2,571,450 | 0.0% | 2.77% | -34.7% |
| Q1 2019 | $17,640,000 | +118.0% | 2,571,450 | +16.9% | 4.25% | +103.4% |
| Q4 2018 | $8,092,000 | -41.9% | 2,199,011 | 0.0% | 2.09% | -18.1% |
| Q3 2018 | $13,920,000 | -16.4% | 2,199,011 | 0.0% | 2.55% | -26.1% |
| Q2 2018 | $16,647,000 | -5.4% | 2,199,011 | 0.0% | 3.45% | +18.1% |
| Q1 2018 | $17,592,000 | -28.6% | 2,199,011 | 0.0% | 2.92% | -26.9% |
| Q4 2017 | $24,629,000 | -3.4% | 2,199,011 | 0.0% | 3.99% | -56.1% |
| Q3 2017 | $25,509,000 | – | 2,199,011 | – | 9.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
| Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
| Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
| Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
| EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
| DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
| Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
| Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |